A. M. Shkatova

A. M. Shkatova

Auto-generated profile, based on publicly available information

A. M. Shkatova

Burdenko Neurosurgical Center

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
DKD.N. Kopachev
D.N. Kopachev
LSL.V. Shishkina
L.V. Shishkina
ASA.M. Shkatova
A.M. Shkatova
AGA.L. Golovteev
A.L. Golovteev
ATA.A. Troitsky
A.A. Troitsky
AGArtem Gushcha
Artem Gushcha
ЦЕЛЬ ИССЛЕДОВАНИЯ Суммировать данные о рентгенологической и гистологической диагностике доброкачественных опухолей, ассоциированных с эпилепсией, а также привести рекомендации по хирургическому лечению эпилепсии при данных опухолях. МАТЕРИАЛ И МЕТОДЫ Использованы статьи из базы медицинской литературы PubMed, а также собственные клинические данные. РЕЗУЛЬТАТЫ Доброкачественные глионейрональные опухоли являются второй по частоте причиной структурной фармакорезистентной эпилепсии у взрослых после склероза гиппокампа. Крайне медленный рост, локализация в коре головного мозга, наличие нейрональной ткани в строме опухоли и сопутствующая эпилепсия являются общими характеристиками этих новообразований. Сложность лечения глионейрональных опухолей заключается в сочетании эпилептологического и нейроонкологического аспектов. Эпилептогенная зона может выходить за пределы опухоли, поэтому ее изолированной резекции может оказаться недостаточно для прекращения приступов. ЗАКЛЮЧЕНИЕ С нейроонкологической точки зрения глионейрональные опухоли являются новообразованиями с очень низким пролиферативным потенциалом, однако необходима их тщательная дифференциальная диагностика с более агрессивными глиальными опухолями; эта задача может быть крайне сложной, но выполнимой методами гистологии и иммуногистохимии.

1 January 2015 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Open access
AKA. N. Konovalov
A. N. Konovalov
DPD. I. Pitskhelauri
D. I. Pitskhelauri
AMA. G. Melikyan
A. G. Melikyan
LSL. V. Shishkina
L. V. Shishkina
NSN. K. Serova
N. K. Serova
DKD. N. Kopachev
D. N. Kopachev
Despite the advances in microsurgery, the choice of the most adequate approach to the posterior part of the medial temporal region (MTR) remains a very controversial issue. The supracerebellar transtentorial approach (STA) is considered as the most preferable one, since it provides the optimal balance between retraction, incision, and resection of the brain tissue. Here, we present our consecutive series of 20 patients who underwent STA surgery. Twenty patients with glial tumors affecting the posterior MTR underwent STA surgery between 2006 and 2014. The mean age of the patients was 20 years. Benign tumors were predominant (18 out of 20 cases). Resection of the posterior and middle MTRs was conducted in 16 cases. The anterior MTR was accessed through STA in 1 patient only; in 2 patients, STA was combined with the infraoccipital approach. Cerebellar edema occurred in 4 patients, with hemiparesis persisting in one of the cases for 1 year after surgery. Of 8 patients with drug resistant epilepsy, the Engel class 1 or 2 outcome was achieved in 6 cases within 1 year after surgery. STA provides an excellent surgical route to the posterior and middle MTR portions; however, the anterior MTR portions cannot be reached safely. The operative risks of STA increase as the surgeon proceeds with resection of the anterior MTR portions. Anterior MTR structures can be removed using a combination of the supracerebellar and infraoccipital transtentorial approaches or two-stage resection.

29 March 2021 in Almanac of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ABA. A. Baev
A. A. Baev
EPE. L. Pogosbekian
E. L. Pogosbekian
NZN. E. Zakharova
N. E. Zakharova
DPD. I. Pitskhelauri
D. I. Pitskhelauri
ABArtem Batalov
Artem Batalov
IPIgor Pronin
Igor Pronin
Background: The use of magnetic resonance (MR) tractography in neurosurgery is becoming an increasingly common practice for noninvasive imaging of white matter pathways. The most common method of tract reconstruction is the deterministic algorithm of diffusion tensor magnetic resonance imaging (MRI). However, this method of reconstructing pathways has a number of significant limitations. The most important of them are the lack of the possibility of visualizing the intersecting fibers, the complexity of building tracts in the area of perifocal edema and in the immediate vicinity of the tumor borders. The method of MR tractography, based on obtaining a diffusion image with a high angular resolution (High Angular Resolution Diffusion Imaging, HARDI), using the constrained spherical deconvolution (CSD) algorithm for post-processing of data, makes it possible to avoid these disadvantages. Relatively recently, a new algorithm, Single-Shell 3-Tissue CSD (SS3TCSD), has been proposed for processing HARDI data, which has the potential to improve the reconstructing of pathways in the area of perifocal edema or edema-infiltration.Aim: To evaluate the potential of the new SS3TCSD algorithm compared to ST-CSD (Single-Tissue CSD) in the imaging of the optic radiation and visual tracts in patients with gliomas.Materials and methods: Diffusion and routine brain MRI was performed in 10 patients with newly diagnosed cerebral gliomas, followed by reconstruction of the optic radiation and visual tracts. We compared new algorithms for postprocessing MR tractography (ST-CSD and SS3TCSD) in imaging of the optic tract and visual radiation in patients with brain gliomas affecting various parts of the visual system.Results: The SS3T-CSD method showed a lower mean percentage of false positive tracts compared to the ST-CSD method: 19.75% for the SS3T-CSD method and 80.32% for the ST-CSD method in cases of proximity of the tumor to the tracts, 5.27% for the SS3T-CSD method and 25.27% for the STCSD method in cases of reconstructing tracts in healthy white matter.Conclusion: The SS3T-CSD method has a number of advantages over ST-CSD and allows for successful imaging of the optic pathways that have a complex structure and repeatedly change direction along their course.

29 March 2024 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
DKD.N. Kopachev
D.N. Kopachev
MRM.V. Ryzhova
M.V. Ryzhova
AKA.N. Kislyakov
A.N. Kislyakov
ESE.G. Shaikhaev
E.G. Shaikhaev
OZO.G. Zheludkova
O.G. Zheludkova
AGA.O. Gushcha
A.O. Gushcha
Background. Methylation analysis has become a powerful diagnostic tool in modern neurooncology. This technique is valuable to diagnose new brain tumor types. Objective. To describe the MRI and histological pattern of neuroepithelial tumor with PLAGL1 gene fusion. Material and methods. We present a 6-year-old patient with small right frontal intraaxial tumor causing drug resistant epilepsy. Despite indolent preoperative clinical course and MRI features suggesting glioneuronal tumor, histological evaluation revealed characteristics of high-grade glioma, ependymoma and neuroblastoma. Results. Methylation analysis of tumor DNA confirmed a new type of a recently discovered neoplasm — neuroepithelial tumor with PLAGL1 fusion (NET PLAGL1). PCR confirmed fusion of PLAGL1 and EWSR1 genes. No seizures were observed throughout the follow-up period. There was no tumor relapse a year after surgery. Conclusion. Methylation analysis in neurooncology is essential for unclear tumor morphology or divergence between histological and clinical data. In our case, this technique confirmed benign nature of tumor, and we preferred follow-up without unnecessary adjuvant treatment.